Monoclonal antibody therapy of T cell lymphoma: single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (Humax-CD4). (2009). Hematology Meeting Reports, 3(1). https://doi.org/10.4081/hmr.v3i1.532